ECG       



2D ECHO


     30/07/2021

                                                     HEMOGRAM

 
PROVISIONAL DIAGNOSIS

        CKD on MHD secondary to Hypertensive nephropathy

 DIAGNOSIS       

            Heart failure with preserved ejection fraction

PLAN OF MANAGEMENT

      Renal Transplantation

        Discussion is going on regarding ABO Compatibility

TREATMENT

Fluid restriction <1L/day

Salt restriction <2.4L/day

T.Lasix 40mg PO/BD

SAM – 4pm

T.Nicardia 20mg PO/TID

T.Arkamine 0.1 mg PO/BD


SHORT CASE-2:

80 year old Female who has sedentary life style without much physical activity, has been diagnosed with Hypertension 5 years back, she was put on Telma H - 40/12.5mg since then. Patient was apparently symptomatic till August 2nd night, then she experienced

Two episodes of loose stools which has foul smell, yellow in color, sticky in consistence, and there is no associated tenesmus, also experienced
Three episodes of vomiting, no odor, food particles seen, non bile stained, and non projectile
As her daughter-in-law is a pharmacist, she gave her eldoper capsule and then stools subsided but patient developed fever with chills and rigor associated with vomiting next day morning, after patient has visited Narketpally KIMS hospital where she was treated with I.V fluids, ORS, Sporolac and other symptomatic treatment 
Upon enquiry she has explained us that her daily water intake used to be boiled Sagar water but on this particular day she drank Sagar water without boiling, all her family members used to drink filter water. None of the people in the same community have experienced any illness who drank Sagar water without boiling.





Patient is conscious, coherent and co-operative, heavy built and moderately nourished
Upon general examination from head to toe, 
Hair is thin and grey in color
Eyebrows, eyes, nose, lips appear normal
Neck short with double chin
Truncal obesity present
Hands and legs appear normal
 Vitals
BP - 90/60 mm of hg
Pulse rate - 100 bpm
Temperature - 103 degree Fahrenheit
GRBS - 126 mg/DL
Respiratory rate - 20 cycles/min
SPO2 - 96% at room
Pallor - Present
No cynosis, No clubbing, No icterus, No edema, No lymphadenopathy
Tongue dry, Skin Turgor lost, Capillary refilling time - 5secs
Systemic Examination
Cardiovascular System - S1 and S2 heard, No thrills, No cardiac murmurs
Respiratory System
Vesicular breath sounds heard
Trachea is in central position
No wheezing
No Dyspnoea
Central Nervous System
Conscious and normal speech
Normal gait
Sensory and Motor system examination - normal
ABDOMEN 
Obese Abdomen is soft, non tender, No palpable mass, no organomegaly Hernial orifices - normal
Bowel sounds - Present
PROVISIONAL DIAGNOSIS - acute gastroenteritis with known case of hypertension
On the first day of admission 
five episodes of loose stools, three episodes of vomiting, fever with chills, temperature 103 degree Fahrenheit
Treatment Given
IV fluids
Inj. PANTOP 40mg OD
inj. ZOFER 4mg IV SOS
T. DOLO 650mg TID
inj. MONOCEF 1gm IV BD
inj. METROGYL 100ml IV TID
T. SPOROLAC DS TID
inj. NEOMOL 1gm IV SOS (If temp > 101degree Fahrenheit)
Mix ORS Sachet in 1litre water, drink 200ml after each episode of loose stool
INVESTIGATIONS
Hb - 8.8 gm/dl
Total WBC count - 9100 cells/cumm 
Neutrophils - 80%
Lymphocytes - 15%
PCV - 25.5% decreased
Platelet count - 1.76 lakhs/cumm
Serum Creatinine - 2.2 mg/DL
Blood Urea - 69 mg/DL
Sodium - 136 mEq/L
Potassium - 3.2 mEq/L
Chloride - 97 mEq/L
Total Billurubin - 1.18 mg/dl
Direct Billurubin - 0.36 mg/dl
SGOT(AST) - 24 IU/L
SGPT(ALT) - 17 IU/L
ALP - 180 IU/L
Total Proteins - 6.5gm/dl
Albumin - 3.4 gm/dl
USG
Raised echogenicity with grade-1 renal paramchymal changes in bilateral kidneys
on subsequent days of admission 
frequency of loose stools increased (10 to 14) episodes in a day
vomotings and fever subsided
same treatment was continued 
inj. optineuron and T. redotil were added
stool microscophy revealed few inflamatory cells
stool culture was negative
hanging drop test did'nt show any motility of organisms
hanging 
QUESTIONS
Is stool culture helpful in management of acute gastroenteritis
when to start antibiotics in acute gastroenteritis
18100006006 THESIS
AUGUST 2021
TITLE
“ETIOLOGY, MANAGEMENT AND OUTCOME IN PATIENTS WITH HYPONATREMIA IN ICU KIMS, NARKETPALLY”

INTRODUCTION:

Hyponatremia is the most common electrolyte disorder among hospitalized patients and has been associated with increased mortality. Hyponatremia is defined as a serum sodium concentration (Na+less than 135 mEq/L

Serum sodium levels and serum osmolality are normally maintained under precise control by homeostatic mechanisms involving thirst, anti-diuretic hormone and the renal handling of filtered sodium. Hyponatremia occurs in a broad spectrum of patients who are asymptomatic or critically ill.

Patients in whom the serum sodium concentration is greater than 130 mEq/L are usually asymptomatic, whereas those in whom these values are lower may have symptoms. Clinical symptoms vary from individual to individual. Majority of patients with hyponatremia are asymptomatic. Most patients with hyponatremia have non-specific symptoms or symptoms due to an underlying disease or disorder. The clinical manifestations of hyponatremia are produced  by brain swelling and are primarily a function of the rate of fall of serum sodium concentration and not the absolute level. Symptoms occurring early in hyponatremia is usually anorexia, nausea, vomiting. Some patients may have headache and irritability. As serum sodium levels falls further patients develop neuropsychiatry symptoms.

These symptoms range from restlessness, altered consciousness, lethargy, seizures to coma. As the symptomatology vary markedly, the diagnosis of hyponatremia is difficult to establish. Prompt recognition and optimal management of hyponatremia in hospitalized patients may reduce in-hospital mortality and symptom severity, allow for less intensive hospital care, decrease the duration of hospitalization and associated costs and improve the treatment of underlying co morbid conditions and patients’ quality of life. So the treating clinician should have a high index of suspicion to diagnose hyponatremia.

There are serious neurological sequelae associated with hyponatremia and its management. The possible causes of hyponatremia should always be sought in every case. The presence of symptoms and duration of hyponatremia guide the treatment strategy. Thorough evaluation for hyponatremia mandates accurate history taking and clinical examination along with various investigations

AIM:

To study etiology, management and outcome in patients with

hyponatremia in ICU KIMS, Narketpally.

 OBJECTIVES:

   To determine the etiology of clinically significant hyponatremia in ICU patients
To study the management given to these patients
To observe the outcome in these patients
To study the various diseases associated with hyponatremia

 PATIENTS AND METHODS
Place of study         - Intensive Care Unit in Kamineni Institute Of Medical science
Period  of study       - oct 2018 – sept2020

 Type of study           - prospective study

 

Study population      - 60 patients

THE LABORATORY

The Biochemistry lab is a standardized laboratory. The methods used for estimation are:

                                         1.    Serum Sodium – HILITE/Transaminase

 

2.    Serum Potassium – I.S.ELECTRODE (Ion selective

Electrophoresis)

 

3.    UREA – Glutaraldehyde LDH

 

4.    Creatinine – Jaffe Kinetic

 

5.    SUGAR – (GOD/POD/Glucose oxidase peroxidase)

 

6.    LFT – Enzymes – kinetic

 

7.    TFT – Automated ELISA reader

 

8.    Urine Na – I.S.ELECTRODE

 

9.    Urine K – I.S.ELECTRODE

 

10.    Lipids – ENZYMATIC METHOD

 

                                  INCLUSION CRITERIA:

All patients greater than 13 years of age

All patients with sodium values less than 130mmol/l

                               EXCLUSION CRITERIA:

Patients with age less than 13 years

Patients who are treated with mannitol and osmotic diuretics

LINK TO COMPLETE THESIS WITH MASTER CHART:

https://www.scribd.com/document/519437512/Manasa-thesis 

18100006006 CLINICAL COMPETENCIES
AUGUST 10, 2021